MedDataX Logo

Omega-3 Fatty Acid Supplementation in Older Adults

NCT ID: NCT01666392

Last Updated: 2012-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study to determine whether Fish oil (Omega-3 Fatty Acid) supplementation has an impact on inflammation and lean body mass in older adults. The investigators expect that Fish oil supplementation will reduce inflammation and prevent the loss of lean mass compared to placebo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Omega-3 fatty acid Fish oil Muscle mass Muscle strength Older adults Circulating inflammatory cytokines Skeletal muscle mass Upper body strength Lower body strength

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fish oil (Omega-3 fatty acid)

2 capsules/day of ProOmega providing 650mg EPA and 450mg DHA

Group Type EXPERIMENTAL

Omega-3 fatty acid

Intervention Type DIETARY_SUPPLEMENT

Omega-3 fatty acid, Eicosapentaenoic acid+docosahexaenoic acid in capsule form

Soybean oil

2 capsules/day

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Omega-3 fatty acid

Omega-3 fatty acid, Eicosapentaenoic acid+docosahexaenoic acid in capsule form

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ProOmega (Nordic Naturals)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 60 years of age or over

Exclusion Criteria

* Fish, seafood allergies, nut allergies, soy allergies
* Habitual (\>1/week) fish or seafood consumption
* Current Omega-3 supplement use
* Gastrointestinal problems
* Current anti-inflammatory medication use
* Current anticoagulant medication use
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nordic Naturals

INDUSTRY

Sponsor Role collaborator

University of Memphis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zsolt Murlasits

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zsolt Murlasits, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

The University of Memphis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Health and Sport Sciences, The University of Memphis

Memphis, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

#2232

Identifier Type: OTHER

Identifier Source: secondary_id

#2232

Identifier Type: -

Identifier Source: org_study_id